Page last updated: 2024-09-04
apigeninidin and Adenocarcinoma of Lung
apigeninidin has been researched along with Adenocarcinoma of Lung in 1 studies
*Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. [MeSH]
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Arunsi, UO; Ishokare, LO; Kazeem, AI; Owumi, SE; Oyelere, AK; Wu, B | 1 |
Other Studies
1 other study(ies) available for apigeninidin and Adenocarcinoma of Lung
Article | Year |
---|---|
Apigeninidin-rich Sorghum bicolor (L. Moench) extracts suppress A549 cells proliferation and ameliorate toxicity of aflatoxin B1-mediated liver and kidney derangement in rats.
Topics: A549 Cells; Adenocarcinoma of Lung; Aflatoxin B1; Animals; Anthocyanins; Apigenin; Cell Proliferation; Humans; Kidney; Liver; Plant Extracts; Rats; Sorghum | 2022 |